EUVIMEDEUVIMED entdecken
Crossref

Photoinduced Reduction of Novel Dual-Action Riboplatin Pt(IV) Prodrug

Olga O Krasnovskaya iD, Roman A Akasov iD, Daniil V Spector, Kirill G Pavlov, Anna A Bubley, Vladimir A Kuzmin, Alexey A Kostyukov, Evgeny V Khaydukov iD, Elena V Lopatukhina, Alevtina S Semkina, Kseniya Yu Vlasova iD, Sergey A Sypalov und 11 weitere

ACS Applied Materials & Interfaces · 2023

DOI: 10.1021/acsami.3c01771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Olga O Krasnovskaya und 22 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Controlled photoreduction of Pt(IV) prodrugs is a challenging task due to the possibility of targeted light-controlled activation of anticancer agents without affecting healthy tissues. Also, a conjugation of photosensitizers and clinically used platinum drugs into one Pt(IV) prodrug allows combining photodynamic therapy and chemotherapy approaches into one molecule. Herein, we designed the cisplatin-based Pt(IV) prodrug Riboplatin with tetraacetylriboflavin in the axial position. A novel Pt(IV) prodrug is able to act both as a photodynamic therapy (PDT) agent through the conversion of ground-state 3O2 to excited-state 1O2 and as an agent of photoactivated chemotherapy (PACT) through releasing of cisplatin under gentle blue light irradiation, without the requirement of a reducing agent. The light-induced behavior of Riboplatin was investigated using an electrochemical sensor in MCF-7 tumor spheroids. Photocontrolled cisplatin release and ROS generation were detected electrochemically in real time. This appears to be the first confirmation of simultaneous photoactivated release of anticancer drug cisplatin and ROS from a dual-action Pt(IV) prodrug observed from the inside of living tumor spheroids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsAntineoplastic AgentsCisplatinReactive Oxygen SpeciesPlatinumCell Line, Tumor

Stichwörter der Autor:innen

PACTPDTPt(IV) prodrugsROScisplatincontrolled releasenanoelectroderiboflavin

Substanzen

CisplatinProdrugsReactive Oxygen SpeciesAntineoplastic AgentsPlatinum

Autor:innen und Institutionen

  • Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia.
  • National University of Science and Technology (MISIS), Leninskiy Prospect 4, Moscow 119049, Russia.
  • I.M. Sechenov First Moscow State Medical University, Trubetskaya 8-2, Moscow 119991, Russia.
  • Federal Scientific Research Center "Crystallography and Photonics" Russian Academy of Sciences, Leninskiy Prospect 59, Moscow 119333, Russia.
  • Emanuel Institute of Biochemical Physics of the Russian Academy of Sciences, Kosygin Street, 4, Moscow 119334, Russia.
  • Pirogov Russian National Research Medical University (RNRMU), Ostrovitianov 1, Moscow 117997, Russia.

ORCID-Profile: Olga O Krasnovskaya, Roman A Akasov, Evgeny V Khaydukov, Kseniya Yu Vlasova, Alexander N Vaneev, Dmitrii M Mazur, Alexander G Majouga, Elena K Beloglazkina

Förderung

  • Russian Science Foundation

Zitieren

APA

Krasnovskaya, O. O., Akasov, R. A., Spector, D. V., Pavlov, K. G., Bubley, A. A., Kuzmin, V. A., Kostyukov, A. A., Khaydukov, E. V., Lopatukhina, E. V., Semkina, A. S., Vlasova, K. Y., Sypalov, S. A., Erofeev, A. S., Gorelkin, P. V., Vaneev, A. N., Nikitina, V. N., Skvortsov, D. A., Ipatova, D. A., Mazur, D. M., …, & Beloglazkina, E. K. (2023). Photoinduced Reduction of Novel Dual-Action Riboplatin Pt(IV) Prodrug. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c01771

Vancouver

Krasnovskaya OO, Akasov RA, Spector DV, Pavlov KG, Bubley AA, Kuzmin VA, et al. Photoinduced Reduction of Novel Dual-Action Riboplatin Pt(IV) Prodrug. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c01771

BibTeX
@article{Krasnovskaya2023,
  author = {Krasnovskaya, Olga O and Akasov, Roman A and Spector, Daniil V and Pavlov, Kirill G and Bubley, Anna A and Kuzmin, Vladimir A and Kostyukov, Alexey A and Khaydukov, Evgeny V and Lopatukhina, Elena V and Semkina, Alevtina S and Vlasova, Kseniya Yu and Sypalov, Sergey A and Erofeev, Alexander S and Gorelkin, Petr V and Vaneev, Alexander N and Nikitina, Vita N and Skvortsov, Dmitrii A and Ipatova, Daria A and Mazur, Dmitrii M and Zyk, Nikolay V and Sakharov, Dmitry A and Majouga, Alexander G and Beloglazkina, Elena K},
  title = {Photoinduced Reduction of Novel Dual-Action Riboplatin Pt(IV) Prodrug},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  doi = {10.1021/acsami.3c01771}
}
Kostenlos starten →